Haemonetics HAE
NYSE HAE
$101.14 -2.02 (-1.96%)
As of: Sep 10, 2026 · 3:59 PM EDT

Haemonetics (HAE) EPS (Basic) Growth (3y) (2012 - 2026)

Analysis

Haemonetics (HAE) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -12.28%
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 24.18%
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 24.57%
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 19.63%
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 50.64%
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -6.23%
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 29.56%
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 17.98%
10 Haemonetics 4.60 Bn 4.37 Bn 202.80 Mn -3.62%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 -3.62%
Mar 28, 2026 -39.86%
Dec 27, 2025 13.62%
Sep 27, 2025 7.69%
Jun 28, 2025 22.16%
Mar 29, 2025 81.89%
Dec 28, 2024 18.00%
Sep 28, 2024 31.75%
Jun 29, 2024 119.77%
Mar 30, 2024 56.70%
Dec 30, 2023 -0.67%
Sep 30, 2023 -19.69%
Jul 1, 2023 57.26%
Apr 1, 2023 18.54%
Dec 31, 2022 3.35%
Oct 1, 2022 -4.11%
Jul 2, 2022 63.05%
Apr 2, 2022 -22.06%
Jan 1, 2022 8.50%
Oct 2, 2021 -7.16%